Seymour Albert
- SEC CIK
- 0001735324
No open-market purchases or sales filed in the past year.
Current role at each company
- QTTB Q32 Bio Inc.See Remarksas of Sep 8, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Seymour Albert as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2023 (view filing) | Sep 6 | 2 days | Seymour AlbertSee Remarks | SSale | −1.45K | $1.15 | −$1.67K | −1.0%150.9K after | 10b5-1 |
| Jan 11, 2023 (view filing) | Jan 9 | 2 days | Seymour AlbertSee Remarks | SSale | −3.62K | $1.39 | −$5.03K | −2.5%143.2K after | From original |
| Jan 12, 2022 (view filing) | Jan 5 | 7 daysLate | Seymour AlbertChief Scientific Officer | SSale | −1.66K | $3.78 | −$6.28K | −1.2%131.6K after |